364 results on '"Birkbak, Nicolai J."'
Search Results
2. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction
3. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx
4. Exploring the biology of ctDNA release in colorectal cancer
5. Antibodies against endogenous retroviruses promote lung cancer immunotherapy
6. The evolution of non-small cell lung cancer metastases in TRACERx
7. The evolution of lung cancer and impact of subclonal selection in TRACERx
8. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
9. Genomic–transcriptomic evolution in lung cancer and metastasis
10. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
11. Body composition and lung cancer-associated cachexia in TRACERx
12. Pervasive chromosomal instability and karyotype order in tumour evolution
13. Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.
14. Chromosomal instability drives metastasis through a cytosolic DNA response
15. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
16. Using DNA sequencing data to quantify T cell fraction and therapy response
17. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
18. The T cell differentiation landscape is shaped by tumour mutations in lung cancer
19. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction
20. Spatial transformation of multi-omics data unlocks novel insights into cancer biology
21. Foundation Models for Quantitative Biomarker Discovery in Cancer Imaging
22. A clonal expression biomarker associates with lung cancer mortality
23. Neoantigen-directed immune escape in lung cancer evolution
24. GENIUS: GEnome traNsformatIon and spatial representation of mUltiomicS data
25. Author Response: GENIUS: GEnome traNsformatIon and spatial representation of mUltiomicS data
26. Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
27. Supplementary Data from Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer
28. Data from Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer
29. Data from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
30. Supplementary Data from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
31. Supplementary Figures S1 - S6 from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
32. Data from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
33. Supplementary Methods from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
34. Supplementary Table S3 from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
35. Data from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
36. Supplementary Methods, Tables S1 - S2, S4, Figures S1 - S11 from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
37. Supplementary Methods from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
38. Supplementary Figures 1-7 from Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
39. Supplementary Figure from Treatment Represents a Key Driver of Metastatic Cancer Evolution
40. Supplementary Data from Treatment Represents a Key Driver of Metastatic Cancer Evolution
41. Supplementary Tables 1-2 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
42. Supplementary Figure 1 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
43. Supplementary Figure 4 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
44. Supplementary Figure Legends 1-4 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
45. Supplementary Figure 2B from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
46. Supplementary Figure 3 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
47. Supplementary Methods from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
48. Data from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
49. Data from Chromosomal Instability Confers Intrinsic Multidrug Resistance
50. Supplementary Table 1 from Chromosomal Instability Confers Intrinsic Multidrug Resistance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.